MSD acquires cancer therapeutics developer Modifi Biosciences

By Yahoo! Finance | Oct 24, 2024 at 11:03 AM EST

MSD acquires Modifi Biosciences, a cancer therapeutics developer, expanding its portfolio with compounds targeting DNA repair defects in challenging cancers. The deal includes an upfront payment of $30m and potential milestone payments up to $1.3bn.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.